Literature DB >> 11888877

Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C.

O Anthony Stuart1, Arvil D Stephens, Laura Welch, Paul H Sugarbaker.   

Abstract

BACKGROUND: Treatment of carcinomatosis may involve the use of heated intraperitoneal chemotherapy; the cytotoxic solution is administered in the operating room with the abdomen open so that manual distribution results in uniform treatment. The potential risk of this procedure to the operating room personnel has not been previously investigated.
METHODS: Mitomycin C was perfused through the peritoneal cavity, which was partially covered by a plastic sheet. Large volumes of air were suctioned from 5 and 35 cm above the abdominal skin edge. Urine from the surgeon and from the perfusionist were assayed. Sterile gloves worn in the operating room for manipulating the viscera during treatment were assayed for their permeability to mitomycin C. All samples were analyzed by high-performance liquid chromatography.
RESULTS: Analysis of samples of operating room air and urine from 10 procedures showed no detectable levels of mitomycin C. Six tests of three different types of gloves showed a 10-fold range of mitomycin C penetration. The least permeable gloves leaked a mean of 3.8 parts per million over 90 minutes.
CONCLUSIONS: No detectable safety hazard to the surgeon or other operating room personnel was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888877     DOI: 10.1007/bf02557372

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

Review 1.  The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse.

Authors:  E Saladino; F Fleres; S Irato; C Famulari; A Macrì
Journal:  Updates Surg       Date:  2013-08-27

2.  Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs.

Authors:  Laurent Benoit; Nicolas Cheynel; Pablo Ortega-Deballon; Giovanni Di Giacomo; Bruno Chauffert; Patrick Rat
Journal:  Ann Surg Oncol       Date:  2007-10-10       Impact factor: 5.344

3.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

4.  Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Mariangela Desantis; Jean-Louis Bernard; Vincent Casanova; Marianne Cegarra-Escolano; Emmanuel Benizri; Amine M Rahili; Daniel Benchimol; Jean-Marc Bereder
Journal:  Langenbecks Arch Surg       Date:  2014-10-16       Impact factor: 3.445

5.  Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination.

Authors:  Clayton B'Hymer; Thomas Connor; Derek Stinson; Jack Pretty
Journal:  J Chromatogr Sci       Date:  2014-08-16       Impact factor: 1.618

6.  Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.

Authors:  Davood Panahi; Mansour Azari; Mohammad Esmaeil Akbari; Rezvan Zendehdel; Hamid Reza Mirzaei; Hossein Hatami; Yadollah Mehrabi
Journal:  Environ Monit Assess       Date:  2016-03-22       Impact factor: 2.513

7.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.

Authors:  Adrian Cravioto-Villanueva; Magdalena Cavazos; Pedro Luna-Perez; Hector Martinez-Gomez; María Lourdes Ramirez; Juan Solorzano; Hermelindo Montiel; Jesus Esquivel
Journal:  Surg Today       Date:  2016-04-30       Impact factor: 2.549

Review 8.  Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.

Authors:  Aditi Bhatt; Sourabh Mittal; K S Gopinath
Journal:  Indian J Surg Oncol       Date:  2016-02-02

9.  Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?

Authors:  Sara Näslund Andréasson; Helena Anundi; Sig-Britt Thorén; Hans Ehrsson; Haile Mahteme
Journal:  J Oncol       Date:  2010-07-01       Impact factor: 4.375

Review 10.  Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.

Authors:  Kurt Van der Speeten; Oswald Anthony Stuart; Paul H Sugarbaker
Journal:  Curr Drug Discov Technol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.